Indefinite Delivery Contract 75N93023D00015
Award Date
6/20/23
Last Date to Order
6/19/30
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This is a single-award Indefinite Delivery Contract (IDC) issued by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The base contract has a potential value of $124,500,000 and a period of performance through September 28, 2028. The purpose is to provide NIAID Preclinical Development Support...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the U.S. government. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods specializing in biopharmaceutical research and development. The IDC, valued at a ceiling of $48,882,666, covers a broad range of pharmacology studies, animal model development, and...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The $80 million IDC is for manufacturing and characterization services for vaccines and other biologics targeting infectious diseases. Under this IDC, ABL has been issued multiple task orders for a range of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIAID) awarded a single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract to Resourcepath, LLC, a certified Woman-Owned Small Business, to provide a comprehensive array of diagnostic pre-clinical services. The $12 million DIAGNOSTICS PRE-CLINICAL SERVICES PROGRAM IDIQ contract has a 7-year ordering period through June 2030. Under this contract, Resourcepath...
The key products and services being delivered under this federal contract IDV award are to support preclinical development efforts for the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The prime contractor, Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, has been awarded multiple delivery orders under this IDV to provide a range of services including cGMP...
This federal contract indefinite delivery vehicle (IDV) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods. The $98.9 million IDV, titled "Resources to Advance Pediatrics and HIV Prevention Science", covers a range of preclinical development support services including cGMP...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH-NIAID) has awarded a $36 million Indefinite Delivery/Indefinite Quantity (IDIQ) contract for the Diagnostic Pre-Clinical Services Program to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corp. Under this single-award IDIQ contract, Dynport will provide a wide range of services to support the development of in vitro diagnostic products for the...
This Indefinite Delivery Contract is a Multiple Award IDV under the In Vitro Assessments of Antimicrobial Activity master contract awarded by the National Institutes of Health National Institute of Allergy and Infectious Diseases. With a potential value of $30 million, it aims to procure services under Task Area A through January 2026 from List Biological Laboratories, Inc. The IDV seeks to obtain in vitro assessments of antimicrobial activity to support the agency's research efforts. This...
This Indefinite Delivery Contract (IDC) was awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL). The $49.9 million, multiple-award IDC will provide Chemistry, Manufacturing, and Control (CMC) and related services to support the development of drug products from August 2024 through July 2031. The contract aims to obtain a broad range of preclinical services...
The National Institute of Allergy and Infectious Diseases awarded a single-award Indefinite Delivery Indefinite Quantity contract to Pharm-Olam, LLC with a potential value of $30,000,000.00 to provide preclinical services supporting the development of biopharmaceutical therapeutics and diagnostics for infectious diseases. Services will be performed across five task areas: product development planning and evaluation; analytical assay development and product characterization; process development...